OptimizeRxOPRX +5.54%54 FCF Yield % is 13.33 as of Jul. 01, 2026. GuruFocus rates OPRX with a GF Score™ of 54/100 and a GF Value™ of $12.96 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 685 Healthcare Providers & Services companies, OptimizeRx ranks better than 86.72% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
OptimizeRx FCF Yield % Related Terms
OptimizeRx FCF Yield % Historical Data
* Premium members only.
The historical data trend for OptimizeRx's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, OptimizeRx's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OptimizeRx FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, OptimizeRx's FCF Yield % distribution charts can be found below:
* The bar in red indicates where OptimizeRx's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OptimizeRx (OPRX) has a FCF Yield % of 13.33 as of Jul. 01, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on OptimizeRx and its competitors. According to the industry distribution chart, OptimizeRx ranks #91 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 13.3%.
Is OptimizeRx's FCF Yield % too high?
OptimizeRx's current FCF Yield % is 13.33. The Healthcare Providers & Services industry median FCF Yield % is 1.84. OptimizeRx's value of 13.33 is 624.5% above this industry median. Based on the distribution chart, OptimizeRx ranks #91 out of 685 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, OptimizeRx has a GF Score™ of 54/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does OptimizeRx's FCF Yield % compare to CCLD and DH?
According to the Healthcare Providers & Services industry distribution chart, OptimizeRx ranks #91 out of 685 companies for FCF Yield %. This places OptimizeRx in the top 13% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 1.84. OptimizeRx's value of 13.33 is 624.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.84, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OptimizeRx's current FCF Yield % of 13.33 is 624.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on OptimizeRx and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OptimizeRx's current FCF Yield % is 13.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OptimizeRx stock overvalued right now?
Based on GuruFocus' analysis, OptimizeRx (OPRX) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.96, compared to a current price of $5.72 — trading 55.9% below its estimated fair value. The current FCF Yield % is 13.33 and 624.5% above the Healthcare Providers & Services industry median of 1.84. OptimizeRx's overall GF Score™ is 54/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For OptimizeRx (OPRX), the current FCF Yield % is 13.33 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OptimizeRx (OPRX) Overvalued in 2026?
Based on GuruFocus' analysis, OptimizeRx stock appears to be undervalued.
The current stock price of $5.72 is trading 55.9% below its estimated GF Value™ of $12.96.
GuruFocus considers OptimizeRx to be Significantly Undervalued.
Key valuation signals for OPRX:
FCF Yield %: 13.33
GF Value™: $12.96 vs. price of $5.72 (55.9% below fair value)
Industry Position: 624.5% above the Healthcare Providers & Services median (#91 of 685)
No single metric tells the full story. See the OPRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
54GF Score
Get the complete analysis for OPRX
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPRX has been successfully added to your 
